DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Weishaupt C, Strolin A, Kahle B. et al.
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial.
Lancet Haematol 2016;
3: e72-e79
DOI: 10.1016/S2352-3026(15)00251-3. (PMID: 26853646)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.